ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
0.00%
Bitcoin
64,013.55
0.19%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) News

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTC
DateTimeSourceHeadlineSymbolCompany
09/03/202408:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
09/03/202408:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
09/03/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
06/03/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
27/02/202401:06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
24/02/202408:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
14/02/202400:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
14/02/202400:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
08/12/202308:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
30/11/202323:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
18/11/202300:00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
14/11/202300:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
14/11/202300:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
14/11/202300:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
21/10/202307:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
20/10/202321:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
17/10/202308:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
29/09/202307:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
21/09/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
21/09/202322:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
21/09/202322:00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
19/09/202307:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
15/08/202307:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/08/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
12/08/202303:00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
11/08/202306:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
11/08/202306:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
11/08/202306:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
09/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
09/08/202312:30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

Your Recent History

ASX
MQG
Macquarie
NASDAQ
AAPL
Apple
FX
AUDCAD
AUD vs CAD
NYSE
XOM
Exxon Mobil
ASX
ORG
Origin Energy
FX
AUDUSD
AUD vs US Dollar
ASX
NAB
National Australia Bank
FX
EURAUD
Euro vs AUD
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
ASX
ANZ
Australia And New Zealan...
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
ASX
WDC
Westfield
NASDAQ
NVDA
NVIDIA
ASX
XFL
S&P ASX 50
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved